It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...

Fake it ‘til your product makes it. One recent survey found that nearly eight in 10 consumers say they think they’ve read a fake review in the past year. And 84% of consumers say they can’t always ...

With over four years of experience writing in the housing market space, Robin Rothstein demystifies mortgage and loan concepts, helping first-time homebuyers and homeowners make informed decisions as ...